ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
0.00%
Bitcoin
63,780.54
-0.18%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Panbela Therapeutics Inc (PBLA)

  7. Panbela Therapeutics Inc (PBLA) News

PBLA Panbela Therapeutics Inc

1.11
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Panbela Therapeutics Inc PBLA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 1.11 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.11 1.11
more quote information »

Recent News

Date Time Source Heading
02/5/202406:15GLOBEPanbela to Host First Quarter 2024 Earnings Conference Call..
30/4/202422:00GLOBEAcceptance of Eflornithine (DFMO) Abstract for Oral..
27/4/202406:39EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
26/4/202406:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/4/202406:35EDGAR2Form 8-K - Current report
25/4/202423:09EDGAR2Form 25-NSE - Notification filed by national security..
22/4/202422:02EDGAR2Form 8-K - Current report
22/4/202422:00GLOBEPanbela Therapeutics Announces Interim Data Analysis for..
19/4/202406:31EDGAR2Form S-1 - General form for registration of securities under..
18/4/202422:00GLOBEPanbela Announces Poster Presentation at American..
17/4/202422:36EDGAR2Form 8-K - Current report
17/4/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
17/4/202407:29GLOBEPanbela Announces Transfer to OTCQB Market
05/4/202407:17EDGAR2Form DEF 14A - Other definitive proxy statements
30/3/202408:24EDGAR2Form S-1 - General form for registration of securities under..
30/3/202408:08EDGAR2Form POS AM - Post-Effective amendments for registration..
27/3/202407:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/3/202407:12EDGAR2Form 8-K - Current report
27/3/202407:10GLOBEPanbela Provides Business Update and Reports Q4 and FY 2024..
26/3/202422:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
26/3/202407:15EDGAR2Form PRE 14A - Other preliminary proxy statements
13/3/202407:15GLOBEPanbela to Host Fourth Quarter and Year End 2023 Earnings..
07/3/202422:01EDGAR2Form 8-K - Current report
16/2/202400:05EDGAR2Form 8-K - Current report
16/2/202400:00GLOBEPanbela Regains Compliance with Nasdaq Listing Standards for..
14/2/202412:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202409:24EDGAR2Form 8-K - Current report
01/2/202423:15EDGAR2Form 8-K - Current report
01/2/202423:00GLOBEPanbela Announces Closing of Approximately $9.0 Million..
31/1/202409:28EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
31/1/202400:15GLOBEAcceptance of Ivospemin (SBP-101) Abstract for Poster..
29/1/202422:21EDGAR2Form 8-K - Current report
29/1/202422:15GLOBEPanbela Announces Pricing of Approximately $9.0 Million..
26/1/202404:22EDGAR2Form S-1/A - General form for registration of securities..
26/1/202400:54EDGAR2Form S-1/A - General form for registration of securities..
25/1/202423:00GLOBEPanbela Exceeds 50% Enrollment for Aspire Trial in..
22/1/202422:08EDGAR2Form S-1/A - General form for registration of securities..
20/1/202409:20EDGAR2Form 8-K - Current report
19/1/202400:15GLOBEPanbela Announces Publication of Clinical Data Titled: Phase..
17/1/202400:00GLOBEPanbela Announces 1-for-20 Reverse Stock Split Effective..
06/1/202408:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/12/202301:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202301:25EDGAR2Form 8-K - Current report
22/12/202301:15GLOBEPanbela Therapeutics Announces Exercise of Warrants and..
21/12/202322:00EDGAR2Form 8-K - Current report
19/12/202300:15GLOBEPanbela Therapeutics Announces US WorldMeds NDA Approval for..
05/12/202300:00GLOBEPanbela Announces Publication of Abstract Titled: Evaluation..
02/12/202308:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/12/202308:15EDGAR2Form 8-K - Current report
30/11/202300:15GLOBEPanbela Announces 2nd Independent Safety Review of the..

Your Recent History

NASDAQ
PBLA
Panbela Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved